Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00552760 · ClinicalTrials.gov registry record · Phase 4
Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder
A Phase 4 study, sponsored by Lehigh Valley Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
NCT00552760 is a Phase 4 study that has completed, run by Lehigh Valley Hospital. The registered enrollment target is 90 participants.
The verdict
NCT00552760, a Phase 4 study, has completed, sponsored by Lehigh Valley Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether treating sleep difficulties in patients with bipolar disorder also improves their mood stability.
Interventions
- DRUG Placebo
- DRUG Ramelteon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00552760
The ClinicalTrials.gov registry entry for NCT00552760 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lehigh Valley Hospital, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00552760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00552760 about?
NCT00552760 is a clinical study titled "Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder". The purpose of this study is to determine whether treating sleep difficulties in patients with bipolar disorder also improves their mood stability.
What is the current status of trial NCT00552760?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2007-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00552760?
The interventions under investigation include: Placebo (DRUG), Ramelteon (DRUG).
Who is sponsoring clinical trial NCT00552760?
This trial is sponsored by Lehigh Valley Hospital, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.